bluebird bio, Inc.

1.05 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

bluebird bio, Inc. stock is up 23.53% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 41.67% of the previous 11 July’s closed higher than June. In the last 2 Unusual Options Trades, there were 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 May 14:09 16 Jan, 2026 3.50 PUT 200 120
25 Jun 19:22 17 Jan, 2025 15.00 PUT 40 116

About bluebird bio, Inc.

bluebird bio, Inc., researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc.